MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/rmdopen-2023-003365

Медицинская библиотека · RMD open · 2023

Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters.

Cafaro Giacomo, Bartoloni Elena, Baldini Chiara, Franceschini Franco, Riccieri Valeria, Fioravanti Antonella, Fornaro Marco, Ghirardello Anna, Palterer Boaz, Infantino Maria, Rigon Amelia, Del Rosso Stefania, Gerli Roberto, Villalta Danilo, Bizzaro Nicola, FIRMA (Interdisciplinary Forum for the Research on Autoimmune Diseases) Collaborators, FIRMA Collaborators

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

Assessment of circulating autoantibodies represents one of the earliest diagnostic procedures in patients with suspected connective tissue disease (CTD), providing important information for disease diagnosis, identification and prediction of potential clinical manifestations. The purpose of this study was to evaluate the ability of multiparametric assay to correctly classify patients with multiple CTDs and healthy controls (HC), independent of clinical features, and to evaluate whether serological status could identify clusters of patients with similar clinical features.

METHODS

Patients with systemic lupus erythematosus (SLE), systemic sclerosis (SSc), Sjogren's syndrome (SjS), undifferentiated connective tissue disease (UCTD), idiopathic inflammatory myopathies (IIM) and HC were enrolled. Serum was tested for 29 autoantibodies. An XGBoost model, exclusively based on autoantibody titres was built and classification accuracy was evaluated. A hierarchical clustering model was subsequently developed and clinical/laboratory features compared among clusters.

RESULTS

908 subjects were enrolled. The classification model showed a mean accuracy of 60.84±4.05% and a mean area under the receiver operator characteristic curve of 88.99±2.50%, with significant discrepancies among groups. Cluster analysis identified four clusters (CL). CL1 included patients with typical features of SLE. CL2 included most patients with SjS, along with some SLE and UCTD patients with SjS-like features. CL4 included anti-Jo1 patients only. CL3 was the largest and most heterogeneous, including all the remaining subjects, overall characterised by low titre or lower-prevalence autoantibodies.

CONCLUSION

Extended multiparametric autoantibody assay allowed an accurate classification of CTD patients, independently of clinical features. Clustering according to autoantibody titres is able to identify clusters of CTD subjects with similar clinical features, independently of their final diagnosis.

Для цитирования: Cafaro Giacomo, Bartoloni Elena, Baldini Chiara, Franceschini Franco, Riccieri Valeria, Fioravanti Antonella, Fornaro Marco, Ghirardello Anna, Palterer Boaz, Infantino Maria, Rigon Amelia, Del Rosso Stefania, Gerli Roberto, Villalta Danilo, Bizzaro Nicola, FIRMA (Interdisciplinary Forum for the Research on Autoimmune Diseases) Collaborators, FIRMA Collaborators. Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters.. RMD open. 2023. DOI: 10.1136/rmdopen-2023-003365.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.